Form D · Other Health Care
Cognito Therapeutics Group, Inc.
Cambridge, MA · CIK 0002062885
Offering snapshot reported Apr 1, 2025 · SEC filing
- Reported sold
- $196M Offering amount: $196M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 19, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 1, 2025 | Initial | $196,250,015 | No comparison | 23 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-542681
Source: Form D, filed Apr 1, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Laura Brege | Director |
| Stephen Bruso | Director |
| Gerald Chan | Director |
| Christian Howell | Director, Executive |
| Richard Kuntz | Director |
| Helen Liang | Director |
| Jarod Rutledge | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
55 Cambridge Pkwy Suite #102 W
Cambridge, MA, 02142
Cambridge, MA, 02142